Ergolin 0.2mg Injection
Marketer
Lincoln Pharmaceuticals Ltd
Salt Composition
Methylergometrine (0.2mg)
Overview Ergolin 0.2mg Injection
Uterine bleeding following childbirth or termination of pregnancy may be managed with Ergolin 0.2mg Injection. This medication acts on uterine smooth muscle, augmenting contractile force, frequency, and strength to minimize hemorrhage. Administration is strictly by intravenous or intramuscular injection in a hospital setting; self-injection is prohibited. Dosage and frequency are determined by your physician based on your individual needs and response. Your doctor will tailor treatment to optimize symptom relief. Headache, elevated blood pressure, and convulsions are potential side effects; report any concerning symptoms promptly. Strategies to mitigate side effects may be available. Alcohol consumption should be avoided during treatment. Prior to commencing treatment, inform your physician of any pre-existing heart conditions or hypertension, and disclose all other medications currently in use, as interactions may impact Ergolin's efficacy or mechanism of action.
Primary Ingredients of Ergolin 0.2mg Injection
No information provided. Please provide the text you want me to rewrite.
Uses of Ergolin 0.2mg Injection
Hemorrhage postpartum
Major Benefits of Ergolin 0.2mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Ergolin 0.2mg Injection:
- High blood pressure
- Headache
- Seizure
How to use Ergolin 0.2mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Ergolin 0.2mg Injection works:
Ergoline 0.2mg injection, an ergot alkaloid derivative, induces prolonged uterine smooth muscle contractions. This constricts blood vessels, thereby stemming postpartum hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Ergolin 0.2mg Injection lacks established safety data. Seek medical advice before combining them.
PregnancyUNSAFE
Administering Ergolin 0.2mg Injection to pregnant individuals presents a substantial risk. Pregnant women should consult their physician before use, as research in both animal and human subjects indicates considerable potential harm to the fetus.
Breast feedingCAUTION
Administering Ergolin 0.2mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the treatment period and until the medication is fully cleared from their system.
DrivingCONSULT YOUR DOCTOR
The effect of Ergolin 0.2mg Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data on Ergolin 0.2mg Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ergolin 0.2mg Injection to individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Ergolin 0.2mg Injection :
NA
Facts to Know About Ergolin 0.2mg Injection
| Label | Value |
|---|---|
| Chemical Category | Ergoline alkaloids |
| Developing Habits | No. |
| Treatment Category | Obstetrics and Gynecology |
| Actions | Drugs that stimulate uterine contractions and induce abortion |
3,018 People bought this recently